148 Stories, most recent news story added Fri Nov 27, 11:30 am ET
WHO warns countries to stay on guard for H5N1 threats The World Health Organization (WHO) today warned that recently confirmed cases of H5N1 avian influenza in poultry in Egypt, Indonesia, Thailand, and Vietnam serve as a reminder that the virus is still a threat to humans.
Biotech firm Replikins Ltd. today issued its latest biochemical analysis of the H1N1 virus genomic data. It shows that the lethality of the virus has dropped from its peak of 3.7 (s.d. 4.5) during the virus's current outbreak in the spring of 2009 to resting non-epidemic levels this week of 2.0 (s.d. 0.1). The H1N1 infectivity count, however, remains increased.
China must be alert to any mutation or changes in the behavior of the H1N1 swine flu virus because the far deadlier H5N1 bird flu virus is endemic in the country, a leading Chinese disease expert said.
BOSTON, Nov. 25 /PRNewswire/ -- Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus.
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Reportlinker.com announces that a new market research report is available in its catalogue:
Why mall Santas do need the H1N1 vaccine.
Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
WHO warns countries to stay on guard for H5N1 threats The World Health Organization (WHO) today warned that recently confirmed cases of H5N1 avian influenza in poultry in Egypt, Indonesia, Thailand, and Vietnam serve as a reminder that the virus is still a threat to humans.
HOLLY SPRINGS, N.C. -(Dow Jones)- Swiss drug maker Novartis AG (NVS, NOVN.VX) opened a vaccine-manufacturing plant Tuesday designed to make influenza vaccines without relying on decades-old technology that employs millions of chicken eggs to grow viruses.
Cover your sneezes. Stay home if you are sick. Wash those hands. -- read more
GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 8 a.m.
Manila - The World Health Organization (WHO) warned Tuesday of a possible resurgence of bird flu amid new cases of the disease in poultry in Egypt, Indonesia, Thailand and Vietnam. The Manila-based WHO Western Pacific Office said the presence of the ...
LOMA LINDA - If there's a lesson to be learned from the H1N1 influenza virus, it is that the nation's vaccine production must be modernized, a top public-health official said here Monday.
Nov. 24 (Bloomberg) -- A fresh wave of bird flu outbreaks in Egypt, Indonesia, Vietnam and Thailand highlights the threat to public health caused by the H5N1 virus, which risks swapping genes with other influenza strains to spawn new variants, the World Health Organization in Manila said in a statement today.
